SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Abgenix, Inc. (ABGX)
An SI Board Since December 1998
Posts SubjectMarks Bans
590 38 0
Emcee:  Henry Niman Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
440Why Biotech Stocks Are Sedated (BW) After seeing so many startups falter and fabob zagorin-6/2/2005
439Abgenix to Present at Needham & Company's Fourth Annual Biotechnology Cobob zagorin-5/20/2005
438Althea Chang ASCO Conference Trading Hype for Hope By Althea Chang TheStreet.combob zagorin-5/20/2005
437GS: ABGX (IL/N): ASCO update, incremental P2 pantitumumab data, BLA on track potmopgcw-5/19/2005
436Further Phase 2 Data Confirm Panitumumab Single-Agent Antitumor Activity in Patibob zagorin-5/17/2005
435Amgen, Abgenix Drug Charts Lone-Wolf Route By Althea Chang TheStreet.com Staff Rbob zagorin-5/17/2005
434[ ABGX ] Abgenix started at buy by IRG Researchbob zagorin-5/11/2005
433proxy sec.govbob zagorin-5/11/2005
43210k sec.govbob zagorin-5/11/2005
431SSB: ABGX: Waiting for Panitumumab-Ph III Data & BLA Expected By Year-end mopgcw-5/2/2005
430GS: ABGX (IL/N):Panitumumab on track for potential H2 2005 submission, front linmopgcw-5/2/2005
429proxy xml.10kwizard.combob zagorin-4/28/2005
428Amgen, Abgenix Expanding Panitumumab Phase III Work By Karen Pihl-Carey Staff WrIcebrg-4/28/2005
427Phase 3 Clinical Trial Initiated to Evaluate the Use of Panitumumab Therapy for bob zagorin-4/26/2005
426Abgenix Announces First Quarter 2005 Financial Results Tuesday April 26, 4:00 pmbob zagorin-4/26/2005
425ImClone's Erbitux Sales Disappoint (ABGX comment) 04.26.05, 9:44 AM ET Stanbob zagorin-4/26/2005
424not ABGX but related Monoclonal antibody cures West Nile virus-infected mice Bybob zagorin-4/25/2005
423Abgenix to Host Conference Call on First Quarter 2005 Financial Results Monday Abob zagorin-4/18/2005
422[Curagen's CR011 for melanoma: preclinical data at AACR] Message 21238598 tuck-4/17/2005
421Abgenix Announces Data Presentations for Panitumumab at AACR and ASCO Annual Meenigel bates-4/15/2005
420By Barnini Chakraborty Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--Shares of Imbob zagorin-4/13/2005
419SSB: OPINION We provide a summary of key takeaways from our Smith Barney Healthmopgcw-4/5/2005
418Abgenix to Present at the Smith Barney Citigroup 2005 Healthcare Conference 3/23bob zagorin-3/24/2005
417Abgenix Completes Study Enrollment Friday March 18, 2:34 pm ET Abgenix, Amgen Cobob zagorin-3/18/2005
416Panitumumab Pivotal Trial Completes Patient Enrollment Friday March 18, 6:00 am bob zagorin-3/18/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News